Beneficial Effects of Supplementation of the Rare Sugar "D-allulose" Against Hepatic Steatosis and Severe Obesity in Lepob/Lepob Mice

Journal of Food Science

Volumn 80, Issue 7, 2015, Pages H1619-H1626

  Itoh, Kouichi ^a   Mizuno, Shodo ^a,e   Hama, Sayuri ^a,f   Oshima, Wataru ^a   Kawamata, Miku ^a   Hossain, Akram ^b,d   Ishihara, Yasuhiro ^c   Tokuda, Masaaki ^b  

^a TOKUSHIMA BUNRI UNIVERSITY   (Japan)

^b KAGAWA UNIVERSITY   (Japan)

^c HIROSHIMA UNIVERSITY   (Japan)

^d Matsutani Chemical Industry Co   (Japan)

^e SHIKOKU MEDICAL CENTER FOR CHILDREN AND ADULTS   (Japan)

^f OTSUKA PHARMACEUTICAL CO LTD   (Japan)

Author keywords

D allulose; Dietary supplements; Hepatic steatosis; Obesity; Sugar

Indexed keywords

FRUCTOSE; LEPTIN; PSICOSE;

3T3 CELL LINE; ADIPOSE TISSUE; ANIMAL; BODY COMPOSITION; BODY WEIGHT; C57BL MOUSE; CELL DIFFERENTIATION; DEFICIENCY; DIETARY SUPPLEMENT; DRUG EFFECTS; FATTY LIVER; KNOCKOUT MOUSE; LIVER; METABOLISM; MOUSE; NUCLEAR MAGNETIC RESONANCE IMAGING; OBESITY; ORGAN SIZE;

3T3-L1 CELLS; ADIPOSE TISSUE; ANIMALS; BODY COMPOSITION; BODY WEIGHT; CELL DIFFERENTIATION; DIETARY SUPPLEMENTS; FATTY LIVER; FRUCTOSE; LEPTIN; LIVER; MAGNETIC RESONANCE IMAGING; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; OBESITY; ORGAN SIZE;

EID: 84947486930     PISSN: 00221147     EISSN: 17503841     Source Type: Journal    
DOI: 10.1111/1750-3841.12908     Document Type: Article

References (55)

1. Anstee QM, Goldin RD. 2006. Mouse models in nonalcoholic fatty liver disease and steatohepatitis research. Int J Exp Pathol 87:1-16.
2. Baek SH, Park SJ, Lee HG. 2010. D-psicose, a sweet monosaccharide, ameliorates hyperglycemia, and dyslipidemia in C57BL/6J db/db mice. J Food Sci 75:49-53.
3. Bray GA, York DA. 1979. Hypothalamic and genetic obesity in experimental animals - autonomic and endocrine hypothesis. Physiol Rev 59:719-809.
4. Bristol JB, Emmett PM, Heaton, KW, Williamson RC. 1985. Sugar, fat, and the risk of colorectal cancer. BMJ Clin Res Ed 291:1467-70.
5. Burt BA, Pai S. 2001. Sugar consumption and caries risk: a systematic review. J Dent Educ 65:1017-23.
6. Cree GM, Perlin AS. 1968. O-isopropylidene derivatives of D-psicose (D-psicose) and D-erythro-hexopyranos-2, 3-diulose. Can J Biochem 46:765-70.
7. Factbook Country Statistical Profiles in OECD - 2014 edition http://stats.oecd.org/index.aspx?DataSetCode=HEALTH_STAT#
8. Fishbein MH, Gardner KG, Potter CJ, Schmalbrock P, Smith MA. 1997. Introduction of fast MR imaging in the assessment of hepatic steatosis. Magn Reson Imaging 15:287-93.
9. Fowler SD, Greenspan P. 1985. Application of Nile red, a fluorescent hydrophobic probe, for the detection of neutral lipid deposits in tissue sections: comparison with oil red O. J Histochem Cytochem 33:833-36.
10. Gardner C, Wylie-Rosett J, Gidding SS, Steffen LM, Johnson RK, Reader D, Lichtenstein AH; American Heart Association Nutrition Committee of the Council on Nutrition, Physical Activity and Metabolism, Council on Arteriosclerosis, Thrombosis and Vascular Biology, Council on Cardiovascular Disease in the Young, and the American D. 2012. Nonnutritive sweeteners: current use and health perspectives: a scientific statement from the American Heart Association and the American Diabetes Association. Circulation. 126:509-19.
11. Granstrom TB, Takata G, Tokuda M, Izumori K. 2004. Izumoring: a novel and complete strategy for bioproduction of rare sugars. J Biosci Bioeng 97:89-94.
12. Green H, Kehinde O. 1975. An established preadipose cell line and its differentiation in culture. II. Factors affecting the adipose conversion, Cell 5:19-27.
13. Hayashi N, Iida T, Yamada T, Okuma K, Takehara I, Yamamoto T, Yamada K, Tokuda M. 2010. Study on the postprandial blood glucose suppression effect of Dpsicose in borderline diabetes and the safety of long-term ingestion by normal human subjects. Biosci. Biotechnol. Biochem. 74:510-19.
14. Herberg L, Coleman DL. 1977. Laboratory animals exhibiting obesity and diabetes syndroms. Metabolism 26:59-99.
15. Hishiike T, Ogawa M, Hayakawa S, Nakajima D, O'Charoen S, Ooshima H, Sun Y. 2013. Transepithelial transports of rare sugar D-psicose in human intestine. J Agric Food Chem. 61(30):7381-86.
16. Hossain MA, Kitagaki S, Nakano D, Nishiyama A, Funamoto Y, Matsunaga T, Tsukamoto I, Yamaguchi F, Kamitori K, Dong Y, Hirata Y, Murao K, Toyoda Y, Tokuda M. 2011. Rare sugar D-psicose improves insulin sensitivity and glucose tolerance in type 2 diabetes Otsuka long-evans Tokushima fatty (OLETF) rats. Biochem Biophys Res Commun 405:7-12.
17. Hossain MA, Yamaguchi F, Matsunaga T, Hirata Y, Kamitori K, Dong Y, Sui Li, Tsukamoto I, Ueno M, Tokuda M. 2012. Rare sugar D-psicose protects pancreas b-islets and thus improves insulin resistance in OLETF rats. Biochem Biophys Res Commun 425:717-23.
18. Hossain A, Yamaguchi F, Hirose K, Matsunaga T, Sui L, Hirata Y, Noguchi C, Katagi A, Kamitori K, Youyi Dong Y, Ikuko Tsukamoto I, Tokuda M. 2015. Rare sugar D-psicose prevents progression and development of diabetes in T2DM model Otsuka Long-Evans Tokushima Fatty rats. Drug Des Devel Ther 9:525-35.
19. Iida T, Kishimoto Y, Yoshikawa Y, Hayashi N, Okuma K, Tohi M, Yagi K, Matsui T, Izumori K. 2008. Acute D-psicose administration decreases the glycemic responses to an oral maltodextrin tolerance test in normal adults. J Nutr Sci Vitaminol 54:511-14.
20. Ingalls AM, Dickie MM, Snell GD. 1950. Obese, a new mutation in the house mouse. J Hered 41:317-18.
21. Johnso RJ, Segal MS, Sautin Y, Nakagawa T, Feig DI, Kang DH, Gersch MS, Benner S, Sánchez-Lozada LG. 2007. Potential role of sugar (fructose) in the epidemic of hypertension, obesity, and the metabolic syndrome, diabetes, kidney disease, and cardiovascular disease. Am J Clin Nutr 86:899-906.
22. Goodpaster BH, Theriault R, Watkins SC, Kelley DE. 2000. Intramuscular lipid content is increased in obesity and decreased by weight loss. Metabolism 49:467-72.
23. Granstrom TB, Takata G, Tokuda M, Izumori K. 2004. Izumoring: a novel and complete strategy for bioproduction of rare sugars. J Biosci Bioeng 97:89-94.
24. Lillie RD, Ashburn LL. 1943. Supersaturated solutions of fat stains in dilute isopropanol for demonstration of acute fatty degeneration not shown by Herxheimer's technique. Arch Pathol 36:432-40.
25. Ludwig J, Viggiano TR, Mcgill DB, Oh BJ. 1980. Nonalcoholic steatohepatitis: mayo clinic experiences with a hitherto unnamed disease. Mayo Clin Proc 55:434-38.
26. Ludwig DS, Peterson KE, Gortmaker SL. 2001. Relation between consumption of sugar-sweetened drinks and childhood obesity: a prospective, observational analysis. Lancet 357:505-08.
27. Marchesini G, Brizi M, Morselli-Labate AM, Bianchi G, Bugianesi E, McCullough AJ, Forlani G, Melchionda N. 1999. Association of nonalcoholic fatty liver disease with insulin resistance. Am J Med 107:450-55.
28. Matsuo T, Izumori K. 2006. Effects of dietary D-psicose on diurnal variation in plasma glucose and insulin concentrations of rats. Biosci Biotechnol Biochem 70:2081-85.
29. Matsuo T, Izumori K. 2009. D-psicose inhibits intestinal alpha-glucosidase and suppresses the glycemic response after ingestion of carbohydrates in rats. J Clin Biochem Nutr. 45:202-06.
30. Matsuo T, Baba, Y, Hashiguchi M, Takeshita K, Izumori K, Suzuki H. 2001. Dietary D-psicose, a C-3 epimer of D-fructose, suppresses the activity of hepatic lipogenic enzymes in rats. Asia Pacific J Clin Nutr 10:233-37.
31. Matsuo T, Suzuki H, Hashiguchi M, Izumori K. 2002. D-psicose is a rare sugar that provides no energy to growing rats. J Nutr Sci Vitaminol. 48:77-80.
32. Mayer J, Bates MW, Dickie MM. 1951. Hereditary diabetes in genetically obese mice. Sci 113:746-47.
33. Milich R, Wolraich M, Lindgren S. 1986. Sugar and hyperactivity: a critical review of empirical findings. Clin Psychol Rev 6:493-513.
34. Montague CT, Farooqi IS, Whitehead JP, Soos MA, Rau H, Wareham NJ, Sewter CP, Digby JE, Mohammed SN, Hurst JA, Cheetham CH, Earley AR, Barnett AH, Prins JB, O'Rahilly S. 1997. Congenital leptin deficiency is associated with severe early-onset obesity in humans. Nature 387:903-08.
35. Mozaffarian D, Hao T, Rimm EB, Willett WC, Hu FB. 2011. Changes in diet and lifestyle and long-term weight gain in women and men. N Engl J Med 364:2392-404.
36. Mu W, Zhang W, Feng Y, Bo J, Zhou L. 2012. Recent advances on applications and biotechnological production of D-psicose. Appl Microbiol Biotechnol 94:1461-67.
37. Nagata Y, Kanasaki A, Tamaru S, Tanaka K. 2015. D-Psicose, an epimer of D-fructose, favorably alters lipid metabolism in Sprague-Dawley rats. J Agric Food Chem. 63:3168-76.
38. OECD Health Statistics, 2012. OECD Publishing
39. Oshima H, Kimura I, Izumori K. 2006. Psicose contents in various food productions and its origin. Food Sci Technol Res 12:137-43.
40. Poulos SP, Dodson MV, Hausman GJ, 2010. Cell line models for differentiation: preadipocytes and adipocytes, Exp. Biol. Med. 235:1185-93.
41. Powell EE, Cooksley WG, Hanson R, Searle J, Halliday JW, Powell LW. 1990. The natural history of nonalcoholic steatohepatitis: a follow-up study of 42 patients for up to 21 years. Hepatology 11:74-80.
42. Reeder SB, Cruite I, Hamilton G, Sirlin CB. 2011. Quantitative Assessment of Liver Fat with Magnetic Resonance Imaging and Spectroscopy. J Magn Reson Imaging 34:729-49.
43. Rinella ME, McCarthy R, Thakrar K, Finn JP, Rao SM, Koffron AJ, Abecassis M, Blei AT. 2003. Dual-echo, chemical shift gradient-echo magnetic resonance imaging to quantify hepatic steatosis: implications for living liver donation. Liver Transpl 9:851-56.
44. Phillips M, Enan E, Liu PCC, Matsumura F. 1995. Inhibition of 3T3-L1 adipose differentiation by 2, 3, 7, 8-tetrachlorodibenzo-pdioxin. J Cell Sci 108:395-402.
45. Saltiel AR. 2001. New perspectives into the molecular pathogenesis and treatment of type 2 diabetes. Cell 104:517-29.
46. Sanyal AJ. 2002. AGA technical review on nonalcoholic fatty liver disease. Gastroenterology 123:1705-25.
47. Sass DA, Chang P, Chopra KB. 2005. Nonalcoholic fatty liver disease: a clinical review. Dig Dis Sci 50:171-80.
48. Smith Jr DL, Johnson MS, Nagy TR. 2009. Precision and accuracy of bioimpedance spectroscopy for determination of in-vivo body composition in rats. Intl J Body Comp Res 7:21-26.
49. Takeshita K, Suga A, Takada G, Izumori K. 2000. Mass production of D-psicose from D-fructose by a continuous bioreactor system using immobilized D-tagatose 3- epimerase. J. Biosci. Bioeng. 90:453-55.
50. Te Morenga L, Mallard S, Mann J. 2012. Dietary sugars and body weight: systematic review and meta-analyses of randomised controlled trials and cohort studies. BMJ 346:e7492.
51. Valls C, Iannacconne R, Alba E, Murakami T, Hori M, Passariello R, Vilgrain V. 2006. Fat in the liver: diagnosis and characterization. Eur Radiol 16:2292-308.
52. vanBaak MA, Astrup A. 2009. Consumption of sugars and body weight. Obes Rev 10(suppl 1):9-23.
53. Wang Y, Rimm EB, Stampfer MJ, Willett WC, Hu FB. 2005. Comparison of abdominal adiposity and overall obesity in predicting risk of type 2 diabetes among men. Am J Clin Nutr 81:555-63.
54. Wise LS, Green H. 1979. Participation of one isozyme of cytosolic glycerophosphate dehydrogenase in the adipose conversion of 3T3 cells. J Biol Chem 254:273-75.
55. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. 1994. Positional cloning of the mouse obese gene and its human homologue. Nature 372:425-32.